StockData
ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) income statement

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.91−0.01 (-0.86%)

Close on Oct 19, 2026Market cap $23.71MP/E –Yield –

See a number that looks wrong?